Client Reported Outcomes: Parkinson's Disease

Celltex conducted a registry study based on the reported results of our clients with Parkinson’s disease (PD).

The study utilized a number of survey methods to assess the reported results of clients with PD who received MSC therapy between March 2012 and December 2020.

View this document for a detailed overview of our reported results for PD.

Click above to access this document.

Learn More